Skip to content

Study · Not a test of the peptide alone · 1992

5 results

Sex differences in the regulation of oxytocin receptors by ovarian steroids in the ventromedial hypothalamus of the rat.

Coirini H, Johnson AE, Schumacher M, McEwen BS

Neuroendocrinology1 Mar 1992Cited by 32 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone5

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In rats of both sexes, estradiol benzoate increased oxytocin receptor density in the medial and caudal ventromedial nucleus of the hypothalamus.

    In plain wordsIn male and female rats, estradiol benzoate increased oxytocin receptor density in part of the hypothalamus.

    Peptide
    Oxytocin
    Outcome
    IncreaseOxytocin receptor density in VMN after estradiol benzoate
    Study

    ratn: not reported in source

    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Source sentences

    Summary
    In both sexes, EB increased the density of OTR and the area covered by the receptors at the level of the medial and caudal VMN.
    1 context sentence
    Summary · context
    In the present study, we compared the effects of EB and P on OTR binding between males and females.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 02AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In rats of both sexes, estradiol benzoate increased the area covered by oxytocin receptors in the medial and caudal ventromedial nucleus.

    In plain wordsIn male and female rats, estradiol benzoate enlarged the area covered by oxytocin receptors in part of the hypothalamus.

    Peptide
    Oxytocin
    Outcome
    IncreaseOxytocin receptor area in VMN after estradiol benzoate
    Study

    ratn: not reported in source

    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Source sentences

    Summary
    In both sexes, EB increased the density of OTR and the area covered by the receptors at the level of the medial and caudal VMN.
    1 context sentence
    Summary · context
    In the present study, we compared the effects of EB and P on OTR binding between males and females.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  3. 03AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In estrogen-primed female rats, progesterone further increased oxytocin receptor levels in the medial ventromedial nucleus.

    In plain wordsIn female rats primed with estrogen, progesterone further increased oxytocin receptor levels in part of the hypothalamus.

    Peptide
    Oxytocin
    Outcome
    IncreaseOxytocin receptor level in medial VMN after progesterone in estrogen-primed females
    Study

    ratn: not reported in source

    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Source sentences

    Summary
    In estrogen-primed females, P further increased OTR levels in the medial VMN
    1 context sentence
    Summary · context
    In the present study, we compared the effects of EB and P on OTR binding between males and females.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  4. 04AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In estrogen-primed female rats, progesterone further increased the area covered by oxytocin receptors at the caudal level of the ventromedial nucleus.

    In plain wordsIn female rats primed with estrogen, progesterone further enlarged the area covered by oxytocin receptors in part of the hypothalamus.

    Peptide
    Oxytocin
    Outcome
    IncreaseOxytocin receptor area in caudal VMN after progesterone in estrogen-primed females
    Study

    ratn: not reported in source

    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Source sentences

    Summary
    In estrogen-primed females, P further increased OTR levels in the medial VMN and the area covered by OTR at the level of the caudal VMN.
    1 context sentence
    Summary · context
    In the present study, we compared the effects of EB and P on OTR binding between males and females.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  5. 05AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In estrogen-primed male rats, progesterone did not modulate oxytocin receptor binding.

    In plain wordsIn male rats primed with estrogen, progesterone did not change oxytocin receptor binding.

    Peptide
    Oxytocin
    Outcome
    No significant changeOxytocin receptor binding after progesterone in estrogen-primed males
    Study

    ratn: not reported in source

    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Source sentences

    Summary
    By contrast, P did not modulate OTR binding in estrogen-primed males.
    1 context sentence
    Summary · context
    In the present study, we compared the effects of EB and P on OTR binding between males and females.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.